Answers are grounded in this paper and cite their sources.
Introduction: Hypertriglyceridemic acute pancreatitis (HTG-AP) is an increasingly prevalent condition that carries a high risk of progression to severe HTG-AP (HTG-SAP) with organ failure (OF). However, widely used early severity scoring systems such as the BISAP score do not incorporate lipid-related biomarkers, despite the central role of lipid dysregulation in HTG-AP pathogenesis. This study aimed to evaluate whether incorporating apolipoprotein A-I (Apo A-I) or triglyceride (TG) levels into the BISAP score, creating lipid-augmented models, could enhance early prediction of adverse clinical outcomes. Methods: We retrospectively included 275 HTG-AP patients from two tertiary centers. Serum lipid profiles and BISAP scores were recorded within 24 hours of admission. The early predictive performance of lipid-augmented models (BISAP-Apo A I and BISAP-TG) for HTG SAP and OF was compared with BISAP, MCTSI, and CRP using ROC, DeLong’s test, IDI, NRI, and DCA. Optimal ROC derived cut offs for each combined model were applied to stratify patients into high and low risk groups, and differences in local and systemic complication rates and hospital length of stay were analyzed. Results: Lower Apo A-I and higher TG levels on admission were significantly associated with HTG-SAP and OF (both P < 0.01). The BISAP-Apo A-I model demonstrated the highest predictive accuracy (AUC = 0.859 for HTG-SAP; 0.766 for OF), significantly outperforming BISAP alone (ΔAUC = 0.054 and 0.041, respectively; both P < 0.05). The BISAP-TG model also improved prediction of HTG-SAP (AUC = 0.850; P < 0.01), though its benefit for OF was borderline (ΔAUC = 0.035; P = 0.051). Both models outperformed CRP for HTG-SAP; for OF, only BISAP-Apo A-I did so significantly, whereas BISAP-TG did not (P=0.058). Compared with MCTSI, BISAP-Apo A-I showed numerically higher AUCs, although the differences did not reach statistical significance (P = 0.179 for HTG-SAP; P = 0.696 for OF). DCA demonstrated broadly comparable net benefit between the lipid-augmented models and the original BISAP score across most threshold probability ranges. Using ROC-derived thresholds (0.27 for BISAP-Apo A-I; 0.13 for BISAP-TG), early stratification effectively identified high-risk patients who experienced significantly more local/systemic complications and longer hospital stays (both P < 0.01). Conclusion: Lipid-augmented BISAP models improved early prognostic accuracy for HTG-AP. By integrating etiology-specific lipid biomarkers, these models enable timely identification of high-risk patients who may benefit from closer monitoring and earlier intervention.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: